Results 241 to 250 of about 6,372,774 (389)

An endotoxin-induced serum factor that causes necrosis of tumors.

Proceedings of the National Academy of Sciences of the United States of America, 1975
E. Carswell, L. Old, R. Kassel, S. Green, N. Fiore, B. Williamson   +5 more
semanticscholar   +1 more source

Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management

Molecular Oncology, EarlyView.
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez, Asieh Naderi, Kim‐Tuyen Huynh‐Dam, Vitali Sikirzhytski, Ioulia Chatzistamou, Hippokratis Kiaris   +5 more
wiley   +1 more source

Comparative analysis of ALA mediated sonodynamic therapy considering tumor size, light combination and ultrasound delivery in murine cutaneous melanoma. [PDF]

Sci Rep
Ayala ETP, Carvalho ISE, Antunes CA, Mahmood A, Requena MB, Alves F, Pires L, Yakovlev V, Bagnato VS, Pratavieira S.   +9 more
europepmc   +1 more source

Vitamins and Tumor Growth

, 1928
Waro Nakahara, Eiichi Somekawa
openalex   +2 more sources

A CONTRIBUTION TO THE STUDY OF TUMORS FROM THE PRIMITIVE NOTOCHORD [PDF]

, 1921
Noah Lewis
openalex   +1 more source

ITGAV and SMAD4 influence the progression and clinical outcome of pancreatic ductal adenocarcinoma

Molecular Oncology, EarlyView.
In SMAD4‐positive pancreatic ductal adenocarcinoma (PDAC), integrin subunit alpha V (ITGAV) activates latent TGF‐β, which binds to the TGF‐β receptor and phosphorylates SMAD2/3. The activated SMAD2/3 forms a complex with SMAD4, and together they translocate to the nucleus, modulating gene expression to promote proliferation, migration, and invasion. In
Daniel K. C. Lee, Keyue Chen, Ryan Loke, Xiang Li, David Liubart, Golam T. Saffi, Jonathan T. S. Chow, Ché M. P. Melo, Lydia To, Leonardo Salmena   +9 more
wiley   +1 more source

Recent advances in bone and soft tissue tumors: lipomatous tumors [PDF]

, 2012
Creytens, David
core   +1 more source

Proteogenomic characterization of invasive breast tumors in young women. [PDF]

NPJ Breast Cancer
Raj-Kumar PK, Liu J, Soltis AR, Bateman NW, Chen Q, Sturtz LA, Deyarmin B, Pierobon M, Abulez TA, Praveen-Kumar A, Zhang X, Nguyen T, Yan C, Hu Y, Guion K, Hooke JA, Kovatich AJ, Fantacone-Campbell L, Mostoller B, Kvecher L, Somiari S, Steeg PS, Rajagopal PS, Darcy KM, Lee JSH, Dalgard CL, Conrads TP, Petricoin EF, Meerzaman D, Wilkerson MD, APOLLO Research Network, Lin X, Shriver CD, Lipkowitz S, Hu H.   +34 more
europepmc   +1 more source

THE RELATIONS OF EMBRYONIC TISSUE AND TUMOR IN MIXED GRAFTS [PDF]

, 1911
Peyton Rous
openalex   +1 more source

Raphin‐1 mediates the survival and sensitivity to radiation of pediatric‐type diffuse high‐grade glioma via phosphorylated eukaryotic initiation factor 2α‐dependent and ‐independent processes

Molecular Oncology, EarlyView.
Raphin‐1 reduces the survival of PED‐DHGG cells and enhances their radiation sensitivity through both PeIF2α‐dependent and PeIF2α‐independent mechanisms. Raphin‐1 sustains elevated levels of PeIF2α, contributing to its PeIF2α‐dependent effects. Additionally, raphin‐1 interacts with CReP to mediate a separate radiosensitizing pathway that operates ...
Karin Eytan, Moshe Leitner, Amos Toren, Shoshana Paglin, Michal Yalon   +4 more
wiley   +1 more source